Point72 Hong Kong LTD Pfizer Inc Put Options Transaction History

Point72 Hong Kong LTD

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $3.75 Million - $4.57 Million	-85,600 Reduced 91.26%	8,200 $359,000
Q2 2022 Aug 15, 2022	BUY	$46.53 - $55.17 $2.37 Million - $2.81 Million	50,900 Added 118.65%	93,800 $4.92 Million
Q1 2022 May 16, 2022	SELL	$45.75 - $56.69 $3.26 Million - $4.04 Million	-71,300 Reduced 62.43%	42,900 $2.22 Million
Q4 2021 Feb 14, 2022	SELL	$41.32 - $61.25 $1.43 Million - $2.12 Million	-34,600 Reduced 23.25%	114,200 $6.74 Million
Q3 2021 Nov 15, 2021	BUY	$39.25 - $50.42 $2.6 Million - $3.34 Million	66,300 Added 80.36%	148,800 $6.4 Million
Q2 2021 Aug 16, 2021	BUY	$35.91 - $40.68 $1.76 Million - $2 Million	49,100 Added 147.01%	82,500 $3.23 Million
Q1 2021 May 17, 2021	SELL	$33.49 - $37.77 $904,230 - $1.02 Million	-27,000 Reduced 44.7%	33,400 $1.21 Million
Q4 2020 Feb 16, 2021	BUY	$33.47 - $42.56 $2.02 Million - $2.57 Million	60,400 New	60,400 $2.22 Million

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.